about
Repurposing clinically approved cephalosporins for tuberculosis therapyTargeting Mycobacterium tuberculosis and other microbial pathogens using improved synthetic antibacterial peptides.One-step isolation of plasma membrane proteins using magnetic beads with immobilized concanavalin A.WhiB7, an Fe-S-dependent transcription factor that activates species-specific repertoires of drug resistance determinants in actinobacteriaWhiB7, a transcriptional activator that coordinates physiology with intrinsic drug resistance in Mycobacterium tuberculosis.The mycobacterial P55 efflux pump is required for optimal growth on cholesterol.Measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent.Measurements of the in vitro anti-mycobacterial activity of ivermectin are method-dependent--authors' response.Triple oral beta-lactam containing therapy for Buruli ulcer treatment shorteningThe FICI paradigm: Correcting flaws in antimicrobial in vitro synergy screens at their inception
P50
Q28828720-4AC6F0BE-E49B-4005-9980-2BE8E45E21EAQ34616362-F42B99E9-ECC5-4179-9463-E0617E7F6F7FQ37011189-E871E8CC-F915-4AB7-9755-0B5413C1A991Q37348910-D7BF375C-EC2E-4190-A62C-76BDF6623704Q38056150-BE54F005-3C55-4A76-8355-6E5742A1BC45Q40757709-BA73ADEC-5376-408A-BCCB-B8DEA53D2C90Q52766694-D6B458FC-FA57-470F-BF6D-BD1972E2BE67Q52769705-57E45D0D-3C7B-4541-A667-D553FA1EE38FQ64233651-258524BE-E275-4718-A1DF-CCCB58C0CFE6Q92142539-22FED65F-712A-40C5-8DF9-5EAAC6D0D9C8
P50
description
investigador
@es
researcher
@en
name
Santiago Ramón-García
@en
Santiago Ramón-García
@nl
type
label
Santiago Ramón-García
@en
Santiago Ramón-García
@nl
prefLabel
Santiago Ramón-García
@en
Santiago Ramón-García
@nl
P108
P31
P496
0000-0002-8480-0325